March 2016

A recent study on infants in China has successfully demonstrated that primary and booster vaccination with an inactivated poliovirus vaccine (IPV)

Researchers have now developed EBOTAb, a pool of intact ovine immunoglobulin G, which has been shown to neutralize Ebola virus (EBOV) in vitro. The primary target was the highly glycosylated spike of EBOV (EBOV-GP1,2). A protein:adjuvant mixture was injected subcutaneously and equally into 6 …